Literature DB >> 2898255

Absence of excess peripheral muscle fatigue during beta-adrenoceptor blockade.

R G Cooper1, M J Stokes, R H Edwards, R D Stark.   

Abstract

1. In eight normal volunteers, the adductor pollicis (AP) was fatigued using intermittent trains of programmed, supramaximal stimulation at 1, 10, 20, 50, 100 and 1 Hz. Activity protocols were performed both with and without circulatory occlusion, both without and during propranolol 80 mg thrice daily in order to investigate the effects of beta-adrenoceptor blockade on 'peripheral' fatigue mechanisms. 2. The degree of beta-adrenoceptor blockade was assessed by the reduction of exercise tachycardia during cycle ergometry, e.g. pulse rates at 210 watts were reduced from 190 +/- 15 to 127 +/- 5 beats min-1 (mean +/- 1 s.d.) indicating that beta-adrenoceptor blockade was substantial and highly significant (P less than 0.001). 3. Before, during and following fatiguing activity with circulatory occlusion force declines were identical during and without beta-adrenoceptor blockade. During and following activity without occlusion, there were slight declines in force which were questionably significantly different at 20 Hz (P less than 0.05). 4. The compound muscle action potential (CMAP) amplitude, measured from the skin surface over the muscle, was unaltered by beta-adrenoceptor blockade before, during or after activity whether with or without circulatory occlusion. 5. The maximal relaxation rate (MRR) was not significantly reduced in previously unfatigued muscle during beta-adrenoceptor blockade. During activity, both with and without circulatory occlusion, there was no evidence that MRR was reduced significantly more during beta-adrenoceptor blockade. 6. The absence of a convincing effect of beta-adrenoceptor blockade on peripheral fatigue mechanisms may indicate that central mechanisms are involved or that impairments of peripheral force production, of a specific nature or as a result of exacerbation of limitations of circulatory oxygen transport, though small are detected during voluntary exercise and give rise to increases in motor unit recruitment and/or firing rates, and hence increased perception of fatigue.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898255      PMCID: PMC1387801          DOI: 10.1111/j.1365-2125.1988.tb03323.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  34 in total

Review 1.  Actions of sympathomimetic amines and their antagonists on skeletal muscle.

Authors:  W C Bowman; M W Nott
Journal:  Pharmacol Rev       Date:  1969-03       Impact factor: 25.468

2.  The beta-2 receptor mediated glycogenolytic responses to catecholamines in the dog.

Authors:  A Arnold; J P McAuliff; D F Colella; W V O'Connor; T G Brown
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-12

3.  Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man.

Authors:  S Epstein; B F Robinson; R L Kahler; E Braunwald
Journal:  J Clin Invest       Date:  1965-11       Impact factor: 14.808

4.  Muscle lactate accumulation during exercise following beta-adrenergic blockade.

Authors:  P Kaiser; P A Tesch
Journal:  Acta Physiol Scand       Date:  1983-01

5.  Leg blood flow during exercise in man.

Authors:  L Jorfeldt; J Wahren
Journal:  Clin Sci       Date:  1971-11       Impact factor: 6.124

6.  The effect of circulatory occlusion on isometric exercise capacity and energy metabolism of the quadriceps muscle in man.

Authors:  R C Harris; E Hultman; L Kaijser; L O Nordesjö
Journal:  Scand J Clin Lab Invest       Date:  1975-01       Impact factor: 1.713

7.  Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.

Authors:  D J Coltart; D G Shand
Journal:  Br Med J       Date:  1970-09-26

8.  Fatigue of maintained voluntary muscle contraction in man.

Authors:  J A Stephens; A Taylor
Journal:  J Physiol       Date:  1972-01       Impact factor: 5.182

9.  Effect of regional alpha- and beta-adrenergic blockade on blood flow in the resting forearm during contralateral isometric handgrip.

Authors:  B Eklund; L Kaijser
Journal:  J Physiol       Date:  1976-10       Impact factor: 5.182

10.  Myotonia precipitated by propranolol therapy.

Authors:  W Blessing; J C Walsh
Journal:  Lancet       Date:  1977-01-08       Impact factor: 79.321

View more
  2 in total

1.  Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.

Authors:  B Tomlinson; J M Cruickshank; Y Hayes; J C Renondin; J B Lui; B R Graham; A Jones; A D Lewis; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

2.  Normal muscle strength and fatigability in patients with effort syndromes.

Authors:  M J Stokes; R G Cooper; R H Edwards
Journal:  BMJ       Date:  1988-10-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.